Aligos Therapeutics (ALGS) Market Capitalization (2020 - 2026)

Aligos Therapeutics (ALGS) has reported Market Capitalization for 7 consecutive years, with $60.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 19.36% year-over-year to $60.2 million; the trailing twelve-month figure through Jun 2026 stood at $60.2 million (down 19.36% YoY), and the FY2025 full-year result was $92.1 million, down 63.09% from the prior year.
• Market Capitalization fell to $60.2 million in Q2 2026 per ALGS's latest filing, from $77.3 million in the prior quarter.
• Across five years, Market Capitalization topped out at $3.8 billion in Q1 2024 and bottomed at $54.3 million in Q3 2024.
• Historically, Market Capitalization has averaged $868.7 million across 5 years, with a median of $875.2 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization soared 307.76% in 2024, then sank 98.19% in 2025.
• Over 5 years, Market Capitalization stood at $1.0 billion in 2022, then rose by 4.29% to $1.1 billion in 2023, then sank by 76.6% to $249.6 million in 2024, then tumbled by 63.09% to $92.1 million in 2025, then sank by 34.67% to $60.2 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $60.2 million, $77.3 million, and $92.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.